4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-003083
SVP and General Counsel sold 662 shares at $30.00 ($19,860)
- SVP and General Counsel acquired 662 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2020-01-08 | Option exercise | +662 | $6.55 | $4,336 | 1,962 | D: show line 1 in the form |
| Taylor Stacy L SVP and General Counsel | 2020-01-08 | Sale | −662 | $30.00 | $19,860 | 1,300 | D: show line 2 in the form |
| Open-market sales · 662 sh · avg $30.00 · $19,860 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2020-01-08 | Option exercise · Stock Option (Right to Buy) | −662 | 50,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…